Clinical Trials at Drexel Surgery
Phase II ‐ HCC Biomarker Study
The goal of the HCC Biomarker study is to develop a diagnostic blood test that can identify liver cancer in its early stages and predict liver cancer recurrence after surgical resection. Learn more.
The information on these pages is provided for general information only and should not be used for diagnosis or treatment, or as a substitute for consultation with a physician or health care professional. If you have specific questions or concerns about your health, you should consult your health care professional.